Corvus Pharmaceuticals Inc. (CRVS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Corvus Pharmaceuticals In...

    NASDAQ: CRVS · Real-Time Price · USD
    6.16
    0.43 (7.50%)
    At close: Sep 05, 2025, 3:59 PM
    6.11
    -0.81%
    After-hours: Sep 05, 2025, 07:53 PM EDT

    Corvus Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.74M 12.62M 13.16M 63.46M
    Short-Term Investments
    		 43.22M 14.53M 29.14M 5.99M
    Long-Term Investments
    		 12.54M 16.12M 21.88M 34.27M
    Other Long-Term Assets
    		 632K 89K 1.84M 2.55M
    Receivables
    		 216K 63K 633K 539K
    Inventory
    		 n/a n/a -735K -667K
    Other Current Assets
    		 548K 220K 837K 795K
    Total Current Assets
    		 54.41M 27.96M 43.66M 71.31M
    Property-Plant & Equipment
    		 1.33M 1.39M 2.22M 3.19M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 14.5M 17.6M 25.94M 40M
    Total Assets
    		 68.91M 45.55M 68.24M 109.45M
    Account Payables
    		 2.58M 1.52M 1.98M 1.56M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 185K 1.37M 1.23M 1.05M
    Other Current Liabilities
    		 29.83M 1.91M 43K 921K
    Total Current Liabilities
    		 35.4M 6.87M 10.75M 9.69M
    Long-Term Debt
    		 n/a n/a 1.37M 2.6M
    Other Long-Term Liabilities
    		 n/a n/a -1.37M -2.6M
    Total Long-Term Liabilities
    		 937K n/a 1.37M 2.6M
    Total Liabilities
    		 36.34M 6.87M 12.13M 12.29M
    Total Debt
    		 1.12M 1.37M 2.6M 3.65M
    Common Stock
    		 7K 5K 5K 5K
    Retained Earnings
    		 -397.01M -334.72M -307.69M -266.38M
    Comprehensive Income
    		 -1.29M -967K -563K 1.87M
    Shareholders Equity
    		 32.57M 38.68M 56.12M 97.16M
    Total Investments
    		 55.76M 30.65M 51.02M 40.26M

    Add to Watchlist